Edward I. Cullen

Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide.

J. Buxbaum, N. Geoghagen, L. Friedhoff, 2001, The international journal of neuropsychopharmacology.